Abstract: A method for treatment of a vascular lesion. A biomarker insertion device introduces a biomarker into a vascular region. The biomarker binds to a lesion type of a plurality of lesion types. Under ultrasound imaging, an image brightness of an imaged biomarker differs based on the lesion type of the plurality of lesion types to which the biomarker binds. An ultrasound imaging probe of an ultrasound imaging system images the biomarker and produces an image brightness of the imaged biomarker. The lesion type is determined based on the image brightness of the imaged biomarker. A frequency of a high intensity focused ultrasound emission of a non-invasive high intensity focused ultrasound device is tuned based on the determined lesion type. The tuned frequency is applied to the vascular lesion, resulting in the destruction of the vascular lesion.

Abstract: A biopsy system includes a biopsy probe configured to sever tissue to acquire a tissue sample. The biopsy probe has biopsy needle portion having a proximal end, a distal end, and a lumen. A vacuum source is coupled to the lumen. The vacuum source is configured to generate a vacuum to transport the tissue sample through the lumen and expel the tissue sample from the lumen at the proximal end of the biopsy needle portion. An arrangement of compression plates is configured to receive the tissue sample from the proximal end of the biopsy probe and is operable to compress the tissue sample. The arrangement of compression plates has a plurality of impedance measurement electrodes. An impedance measurement circuit is connected to the plurality of impedance measurement electrodes.

Abstract: An adjustable interface device for connecting two components of a medical device includes an elongate body and an elongate member. The elongate body has a first end, a second end, an interior channel, and a side wall that surrounds the interior channel. The side wall defines a first connector portion adjacent the second end. The first connector portion attaches to a respective one of the components of the medical device. The elongate member has a head end portion and a shaft portion that longitudinally extends from the head end portion. The shaft portion is located at least partially in the interior channel of the elongate body. The shaft portion is configured to slidably move axially along the longitudinal axis to adjust a length of the adjustable interface device. The head end portion defines a second connector portion that attaches to another of the components of the medical device.

Abstract: An implant for use in a lung access procedure to aid in preventing pneumothorax includes a tubular body that has a lumen, a proximal end, and a distal end portion that terminates at a distal end. The tubular body has a longitudinal axis and has a side wall that radially surrounds the lumen. The side wall has an exterior surface. An anchor member is connected to the tubular body, wherein the anchor member is movable relative to the tubular body from a collapsed state to a deployed state. At least one suture is connected to the tubular body, wherein the at least one suture extends in a proximal direction from the proximal end of the tubular body.

Abstract: Devices, systems, and methods for providing per-procedure pricing for a product are disclosed. A system includes a facility monitoring system having one or more data gathering devices collecting data pertaining to use of a plurality of units of the product over a period of time. The system also includes a product provider system communicatively coupled to the facility monitoring system and including a determination device that receives the data and determines a total average number of units per procedure for the product, the determination device including a machine learning component trained to determine an expected number of units per procedure and determine a plurality of pricing tiers that establish a price is used to calculate an adjusted per-procedure price for the product over the period of time, the determination device issuing a rebate if the adjusted per-procedure price is less than an upfront cost paid.

Abstract: A method for use in a lung access procedure to aid in preventing pneumothorax includes providing a cannula having a pair of balloons, the pair of balloons including a first balloon longitudinally spaced from a second balloon along the cannula; inserting the cannula along an access opening and through pleural layers of a patient, with the first balloon and the second balloon of the pair of balloons respectively positioned on opposite sides of the pleural layers; inflating the pair of balloons with a first amount of a two-component sealant to compress the pleural layers together; and inflating the pair of balloons with a second amount of the two-component sealant that is sufficient to rupture the pair of balloons so as to comingle a first sealant component and a second sealant component of the two-component sealant at the site of the pleural layers so as to adhere the pleural layers together.

Abstract: A method of operating a marking device includes defining an initial condition wherein a cannula is in an extended position and a stylet is in a ready position in the extended cannula, and, starting from the initial condition with the cannula in the extended position, sequentially: effecting movement of the stylet from a ready position to an implant position, ejecting an imaging marker through a distal opening in a cannula distal end of the cannula, and then; effecting a simultaneous unitary retraction of the cannula and stylet after ejection of the imaging marker from the distal opening in the cannula distal end.

Abstract: A method for use in a lung access procedure to aid in preventing pneumothorax includes providing a cannula having a pair of balloons, the pair of balloons including a first balloon longitudinally spaced from a second balloon along the cannula; inserting the cannula along an access opening and through pleural layers, with the first balloon and the second balloon of the pair of balloons respectively positioned on opposite sides of the pleural layers; inflating the pair of balloons with a first amount of a two-component sealant to compress the pleural layers together; and inflating the pair of balloons with a second amount of the two-component sealant that is sufficient to rupture the pair of balloons so as to comingle a first sealant component and a second sealant component of the two-component sealant at the site of the pleural layers so as to adhere the pleural layers together.

Abstract: A non-compliant fiber-reinforced medical balloon comprises a first fiber layer and a second fiber layer embedded in a continuous matrix of thermally-weldable polymer material defining a barrel wall, cone walls and neck walls. The fibers of the first fiber layer have a pattern of different lengths and are divisible into a first group and a second group based on length. The length of the fibers of the second group varies progressively in accordance to their proximity to the fibers of the first group; the fibers of the second group closest to the fibers of the first group being longer than the fibers of the second group further from the fibers of the first group. The fiber of the second fiber layer winds circumferentially around the longitudinal axis of the balloon substantially over the entire length of the balloon.

Abstract: A non-compliant fiber-reinforced medical balloon comprises a first fiber layer and a second fiber layer embedded in a continuous matrix of thermally-weldable polymer material defining a barrel wall, cone walls and neck walls. The fibers of the first fiber layer run substantially parallel to one another and substantially parallel to the longitudinal axis. The fibers of the first fiber layer have a pattern of different lengths and are divisible into a first group and a second group based on length.

Abstract: A delivery assembly includes a console including a vial containment region and a vial engagement mechanism extending from the console within the vial containment region. The engagement mechanism is configured to engage a vial assembly. The delivery assembly further includes a sled assembly removably coupled to the console at the vial containment region and a safety shield removably coupled to the console over the vial containment region such that the vial engagement mechanism and the sled assembly are encapsulated within the safety shield when the safety shield is coupled thereto. The sled assembly, the vial assembly, and the safety shield are configured to inhibit radioactive emissions from within the vial containment region.

Abstract: A non-compliant medical balloon comprises a base balloon including a pair of spaced-apart, generally conical end sections and a generally cylindrical center section connected therebetween. A braided fabric sleeve surrounds at least a portion of the base balloon, wherein the sleeve is formed of at least three substantially inelastic fibers intertwined in such a way that no two of the three fibers are twisted exclusively around one another. The sleeve is permanently affixed to the outer surface of the base balloon so as to prevent excessive expansion of the base balloon when the base balloon is internally pressurized.

Abstract: A method of delivering a drug in a vessel includes positioning an inflatable balloon that is located at a distal end of an ultrasonic device within a lumen of the vessel, the inflatable balloon being deflated and coated with at least one drug; inflating the inflatable balloon; and transmitting a vibration to the distal end of the ultrasonic device to dislodge the drug from the inflated inflatable balloon and deliver the drug to an interior portion of the vessel.

Abstract: Disclosed herein is an implantable port and an implantable port-detecting device (“IPDD”). The implantable port includes a housing and a septum over a portion of the housing. At least one of the housing or the septum incorporates a contrast agent for locating the septum of the implantable port when the implantable port is implanted in a patient. The IPDD includes a light source, a light detector, and a display configured to display a presence of the implantable port. The light source is configured to emit light in a near-infrared (“NIR”) range of wavelengths as incident light for absorption by the contrast agent. The light detector is configured to detect light in the NIR range of wavelengths including luminescent light emitted by the contrast agent. The display is configured to display a presence of the implantable port when the luminescent light from the contrast agent is detected by the light detector.

Abstract: A catheter comprising a base material, an optional body material, and a braid structure having crescent-shaped ribbons braided into the structure. Various biocompatible polymers can function as base or body materials. When a ribbon is metallic, various biocompatible materials can function in the ribbon. The crescent of a crescent ribbon can face luminally or abluminally.

Abstract: In one aspect, a connector assembly includes a delivery conduit defining a conduit lumen and a securable connector configured to secure the delivery conduit to a medical device hub defining a medical device hub lumen. The conduit lumen includes a constant diameter region along a portion of the delivery conduit and a transition region extending from the delivery conduit to the distal end. A transition region diameter of the transition region gradually increases from the constant diameter region to a distal end of the delivery conduit. The securable connector is coupled to an outer surface of the delivery conduit and is slidable along a portion thereof. The securable connector is configured to receive the medical device hub. The securable connector is secured relative to the delivery conduit so as to fluidically couple the conduit lumen with the medical device hub lumen.

Abstract: An access port for subcutaneous implantation is disclosed. The access port may include a body for capturing a septum for repeatedly inserting a needle therethrough into a cavity defined within the body. The access port may further include at least one feature structured and configured for identification of the access port subsequent to subcutaneous implantation. Methods of identifying a subcutaneously implanted access port are also disclosed. For example, a subcutaneously implanted access port may be provided and at least one feature of the subcutaneously implanted access port may be perceived. The subcutaneously implanted access port may be identified in response to perceiving the at least one feature. In one embodiment, an identification feature is included on a molded insert that is sandwiched between base and cap portions of the access port so as to be visible after implantation via x-ray imaging technology.